Guidelines: Risk assessment and lipid modification for primary and secondary prevention of cardiovascular disease: summary of NICE guidance

Journal List > BMJ > v.336(7655); May 31, 2008

BMJ. 2008 May 31; 336(7655): 1246–1248.

doi: 10.1136/bmj.39554.624086.AD.

PMCID: PMC2405875

Copyright © BMJ Publishing Group Ltd 2008

Practice

Guidelines

Risk assessment and lipid modification for primary and secondary prevention of cardiovascular disease: summary of NICE guidance

Angela Cooper, senior health services research fellow and Norma O’Flynn, clinical director , Guideline Development Group

¹National Collaborating Centre for Primary Care, Royal College of General Practitioners, London SW7 1PU

Correspondence to: N O’Flynn Email: noflynn/at/rcgp.org.uk

Small right arrow pointing to:

See "Commentary: Controversies in NICE guidance on lipid modification for the prevention of cardiovascular disease" on page 1248.

Small right arrow pointing to:

This article has been cited by other articles in PMC.

This item has no abstract.

Image of the link to publisher's site

is available at the Publisher's site, where access restrictions may apply.